Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000206083 | SCV000261929 | benign | Cowden syndrome | 2025-02-03 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001711361 | SCV001159511 | benign | not provided | 2020-12-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001711361 | SCV001941332 | benign | not provided | 2019-01-04 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001579917 | SCV002071021 | benign | not specified | 2018-09-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002453746 | SCV002614210 | likely benign | Inborn genetic diseases | 2022-02-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001711361 | SCV002821230 | benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | PIK3CA: BP4, BP7, BS1, BS2 |
KCCC/NGS Laboratory, |
RCV003316147 | SCV004016565 | benign | Cowden syndrome 5 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001711361 | SCV005302467 | benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001579917 | SCV001809025 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001579917 | SCV001924561 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001711361 | SCV001976160 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001579917 | SCV002035401 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004530242 | SCV004740523 | benign | PIK3CA-related disorder | 2019-04-10 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |